Igalmi buccal/sublingual

Generic name: Dexmedetomidine (buccal/sublingual)
Brand names: Igalmi
Drug class: Miscellaneous anxiolytics , Antineoplastic Agents

Usage of Igalmi buccal/sublingual

Igalmi (buccal/sublingual) is used in adults to treat agitation associated with schizophrenia or bipolar I or II disorder.

The safety and effectiveness of Dexmedetomidine (buccal/sublingual) has not been established after 24 hours from the first use.

Igalmi (buccal/sublingual) may also be used for purposes not listed in this medication guide.

Igalmi buccal/sublingual side effects

Get emergency medical help if you have signs of an allergic Reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Igalmi may cause serious side effects. Call your doctor at once if you have:

fast, slow, or irregular heartbeats; or

a light-headed feeling, like you might pass out.

Common side effects of Igalmi may include:

drowsiness;

dizziness;

numbness, tingling, burning pain;

loss of sensation in the mouth, dry mouth; or

feeling like you might pass out.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Igalmi buccal/sublingual

Tell your doctor if you have ever had:

liver disease;

diabetes;

high blood pressure;

low blood pressure, or if you are dehydrated;

a serious heart condition such as severe heart block;

a heart rhythm disorder; or

long QT syndrome.

It is not known if Igalmi (buccal/sublingual) will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.

If you are breastfeeding, tell your doctor if you notice irritability in the nursing baby.

Relate drugs

How to use Igalmi buccal/sublingual

Follow all directions on your prescription label and read all medication guides or instruction sheets. Your doctor may occasionally change your dose. Use the medicine exactly as directed.

Igalmi (buccal/sublingual) should be administered under the supervision of a healthcare professional.

Place Igalmi under the tongue (sublingual) or behind the lower lip (buccal).

Allow the dissolving film to dissolve, and do not chew or swallow Igalmi (buccal/sublingual).

Do not eat or drink for at least 15 minutes after sublingual use, or at least one hour after buccal use.

Remain sitting or lying down after using Igalmi (buccal/sublingual).

Your vital signs may be watched during treatment.

You may have withdrawal symptoms after you stop using Igalmi (buccal/sublingual). The most common withdrawal reactions are nausea, vomiting, and agitation.

Store Igalmi in the foil pouch at room temperature away from moisture and heat.

Warnings

Use only as directed. Tell your doctor if you use other medicines or have other medical conditions or allergies.

What other drugs will affect Igalmi buccal/sublingual

Igalmi (buccal/sublingual) can cause a serious heart problem. Your risk may be higher if you also use certain other medicines for infections, asthma, heart problems, high blood pressure, depression, mental illness, cancer, malaria, or HIV.

Using Igalmi (buccal/sublingual) with other drugs that make you drowsy can worsen this effect. Ask your doctor before using opioid medication, a sleeping pill, a muscle relaxer, or medicine for anxiety or seizures.

Other drugs may affect Igalmi (buccal/sublingual), including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all other medicines you use.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.